Form 4: UMH Properties EVP and CFO Anna T. Chew Reports Changes in Beneficial Ownership

Sentiment:

SEC Form 4


Anna T. Chew, EVP and CFO of UMH Properties, reported changes in beneficial ownership of the company's stock, including acquisitions through dividend reinvestment and holdings in a 401(k).

Summary

  • On June 17, 2024, Anna T. Chew, the EVP and CFO of UMH Properties, filed a Form 4 to report changes in her beneficial ownership of UMH Properties stock.
  • The report indicates that Chew directly owns 1,037,048.74 shares of UMH Properties.
  • This includes 3,529.87 shares acquired through dividend reinvestment on June 17, 2024, and 50,528 shares held in a 401(k) as of the same date.
  • Chew also holds derivative securities in the form of options to purchase UMH Properties stock at various exercise prices and expiration dates.

Sentiment

Score: 6

Explanation: The document is a standard regulatory filing, indicating routine transactions. The sentiment is neutral as it primarily reflects compliance with reporting requirements.

Positives

  • The reporting of beneficial ownership changes provides transparency to investors.
  • Dividend reinvestment indicates a continued investment in the company by the CFO.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. Investors often monitor these filings to gauge management's sentiment and confidence in the company's prospects.

Stakeholder Impact

  • Shareholders are informed about the ownership stake of a key executive.
  • Employees participating in the 401(k) plan are indirectly impacted by the value of UMH Properties shares.

Key Dates

DateDescription
01/19/2018Date of options grant with an exercise price of $14.25, expiring on 01/19/2027.
04/04/2018Date of options grant with an exercise price of $15.04, expiring on 04/04/2027.
04/02/2020Date of options grant with an exercise price of $13.9, expiring on 04/02/2029.
03/25/2021Date of options grant with an exercise price of $9.7, expiring on 03/25/2030.
07/14/2022Date of options grant with an exercise price of $22.57, expiring on 07/14/2031.
03/28/2023Date of options grant with an exercise price of $23.81, expiring on 03/28/2032.
03/21/2024Date of options grant with an exercise price of $14.36, expiring on 03/21/2033.
06/17/2024Date of dividend reinvestment and 401(k) holdings reported.
03/26/2025Date of options grant with an exercise price of $15.66, expiring on 03/26/2034.
07/03/2024Date of the report.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.